• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Lot Number VMFA210923
Medical Device Problem Code Positioning Problem (3009)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 12/05/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported that a thrombosis occurred.During a left atrial appendage closure (laac) procedure, a versacross connect kit was selected for use.There were difficulties experienced performing the transseptal puncture and several attempts were made for about thirty minutes before the interatrial septum was successfully crossed.A transesophageal echocardiogram (tee) revealed a free floating thrombus in the right atrium and heparin was administered.Act drawn later result was 308.The left atrial appendage (laa) procedure was successfully completed and the patient discharged the same day.The device is not expected to be returned for analysis.
 
Event or Problem Description
It was reported that a thrombosis occurred.During a left atrial appendage closure (laac) procedure, a versacross connect kit was selected for use.There were difficulties experienced performing the transseptal puncture and several attempts were made for about thirty minutes before the interatrial septum was successfully crossed.A transesophageal echocardiogram (tee) revealed a free floating thrombus in the right atrium and heparin was administered.Act drawn later result was 308.The left atrial appendage (laa) procedure was successfully completed and the patient discharged the same day.The device is not expected to be returned for analysis.
 
Additional Manufacturer Narrative
"**udi related data quality updates only**.This report is being filed as a correction in response to an fda request for the complete the unique identifier (udi) #." it was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18360306
Report Number2124215-2023-72334
Device Sequence Number12740806
Product Code DRE
UDI-Device Identifier00685447012573
UDI-Public(01)00685447012573(17)260717(10)VMFA210923
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
K220414
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/17/2026
Device Lot NumberVMFA210923
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer07/09/2024
Initial Report FDA Received Date12/19/2023
Supplement Report FDA Received Date08/06/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age85 YR
Patient SexMale
-
-